Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00936936
What this trial is testing

High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors

Who this might be right for
Testicular Cancer
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Study completedNCT01824693
What this trial is testing

Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia

Who this might be right for
Juvenile Myelomonocytic Leukemia
Children's Oncology Group 30
Not applicableNo Longer AvailableNCT01728051
What this trial is testing

Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

Who this might be right for
Metastatic Liver CancerOcular MelanomaCutaneous Melanoma
Delcath Systems Inc.
Testing effectiveness (Phase 2)Study completedNCT00423514
What this trial is testing

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 38
Not applicableEnded earlyNCT01794572
What this trial is testing

Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse

Who this might be right for
Multiple Myeloma in Relapse
Institut Cancerologie de l'Ouest 13
Large-scale testing (Phase 3)Study completedNCT00324727
What this trial is testing

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)Metastatic Cancer
Delcath Systems Inc. 93
Testing effectiveness (Phase 2)Looking for participantsNCT06607458
What this trial is testing

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

Who this might be right for
Refractory Metastatic Colorectal Cancer
Delcath Systems Inc. 90
Testing effectiveness (Phase 2)Study completedNCT01969435
What this trial is testing

Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma

Who this might be right for
Hodgkin DiseaseLymphoma, Non-Hodgkin
Washington University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT00734149
What this trial is testing

Bortezomib With Melphalan and Prednisone for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Duke University 45
Early research (Phase 1)Study completedNCT00388999
What this trial is testing

Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Enzon Pharmaceuticals, Inc. 46
Large-scale testing (Phase 3)Study completedNCT00217438
What this trial is testing

Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Fred Hutchinson Cancer Center 130
Early research (Phase 1)Study completedNCT01798004
What this trial is testing

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaStage 1 NeuroblastomaStage 2 Neuroblastoma+5 more
Children's Oncology Group 150
Testing effectiveness (Phase 2)Study completedNCT00429572
What this trial is testing

Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 19
Very early researchWithdrawnNCT05013437
What this trial is testing

Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Koen van Besien
Testing effectiveness (Phase 2)Study completedNCT01083316
What this trial is testing

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00004158
What this trial is testing

Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00306735
What this trial is testing

Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.

Who this might be right for
Multiple Myeloma
Eisai Inc. 75
Testing effectiveness (Phase 2)Study completedNCT00572897
What this trial is testing

Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis

Who this might be right for
Myelofibrosis
John Mascarenhas 66
Testing effectiveness (Phase 2)Ended earlyNCT03639610
What this trial is testing

PK of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With RRMM and Impaired Renal Function

Who this might be right for
Renal ImpairmentMultiple Myeloma
Oncopeptides AB 35
Early research (Phase 1)Study completedNCT01936090
What this trial is testing

Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
DS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma+1 more
Mayo Clinic 11
Next Page